NCT03142971

Brief Summary

The aim of this randomized controlled study is to investigate if focal shock wave is an effective treatment, with respect to hip pain and lower limb function, in a population affected by greater trochanteric pain syndrome with gluteal tendinopathy.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2013

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 4, 2016

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

April 28, 2017

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 8, 2017

Completed
Last Updated

May 10, 2017

Status Verified

May 1, 2017

Enrollment Period

3.2 years

First QC Date

April 28, 2017

Last Update Submit

May 9, 2017

Conditions

Keywords

Shock wavesGreater trochanteric pain syndrome

Outcome Measures

Primary Outcomes (2)

  • p-NRS

    Change from baseline p-NRS (pain-on-movement numeric rating scale) at 2 months and at 6 months.

    Baseline, at two months, at six months

  • LEFS score

    Change from baseline LEFS (Lower extremity functional scale) total score at 2 months and at 6 months

    Baseline, at two months, at six months

Study Arms (2)

Intervention:f-ESWT (focused shock wave therapy)

EXPERIMENTAL

In the study-group, a device powered by a piezoelectric generator (PIEZOSON 100PLUS, Richard Wolf) was used . At the beginning of each treatment session, the enthesis of the gluteal tendons at the greater trochanter (at the anterior half of its lateral facet) was targeted through a non-inline sonographic focusing, using a linear probe (7.5-12 MHz) connected to an ultrasound scanner (ESAOTE MYLAB FIVE, Genova and Florence, Italy). All patients received 1800 pulses (frequency=4Hz) of an energy flux density of 0.15 mJ/mm2 once a week for three consecutive weeks. At the first treatment session, the energy flux density was gradually increased from 0.05 to 0.15 mJ/mm2 during the first 500 pulses.

Procedure: focused shock wave therapy

Intervention:UST (ultrasound therapy)

ACTIVE COMPARATOR

In the control-group, we used a mono-frequency device (ROLAND, RT-20 series, frequency=1MHz). We treated an area of 5cm2, softly moving the US-probe around the most painful point of the greater trochanter at the clinical palpation. UST was supplied in a continuous modality, with an intensity of 1.5 W/cm2, for ten consecutive daily sessions of ten minutes each.

Procedure: ultrasound therapy

Interventions

Intervention:f-ESWT (focused shock wave therapy)
Intervention:UST (ultrasound therapy)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • duration of lateral hip pain of six weeks or longer,
  • normal passive hip range of movement (ROM),
  • sonographic evidence of gluteal tendinopathy at their insertional site at the greater trochanter

You may not qualify if:

  • general contraindication to extracorporeal shock wave therapy (pacemaker, pregnancy, bleeding disorders or anticoagulant drug usage, cancer in the focal area),
  • history of rheumatologic disease,
  • previous fractures or surgery in the affected limb,
  • full thickness tear of the gluteal tendons,
  • osteoarthritis of the hip (with ROM limitation),
  • clinical signs of lumbar radiculopathy,
  • corticosteroid injections or other conservative therapies (except pharmacological pain treatments) since the onset of the current pain episode.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Tendinopathy

Interventions

Extracorporeal Shockwave TherapyUltrasonic Therapy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesTendon InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

DiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

April 28, 2017

First Posted

May 8, 2017

Study Start

March 1, 2013

Primary Completion

May 4, 2016

Study Completion

May 4, 2016

Last Updated

May 10, 2017

Record last verified: 2017-05